BioNTech: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
kTidak ada ringkasan suntingan Tag: VisualEditor Suntingan perangkat seluler Suntingan peramban seluler |
kTidak ada ringkasan suntingan Tag: VisualEditor Suntingan perangkat seluler Suntingan peramban seluler |
||
Baris 88:
Pada bulan Juni 2020, EIB kembali mengucurkan pinjaman sebesar €100 juta, setelah pengobatan tersebut disetujui hanya dalam waktu dua bulan, padahal biasanya memakan waktu hingga satu tahun. Pendanaan tersebut pun membantu BioNTech dalam menguji dan memproduksi vaksin. Pinjaman EIB adalah bagian dari program InnovFin Corporate Research Equity dan European Fund for Strategic Investments. Program tersebut mendukung "proyek inovatif dan berisiko tinggi" dengan dukungan dari [[European Investment Bank]] dan jaminan dari anggaran [[Uni Eropa]].<ref>{{Cite web|title=BioNTech moves to head of pack for COVID-19 vaccine with EU finance|url=https://www.eib.org/en/stories/eu-financing-for-covid-19-vaccine|access-date=2021-06-30|website=European Investment Bank|language=en}}</ref><ref>{{Cite journal|date=March 2004|title=EU forks out € 50 million to clean Internet|url=http://dx.doi.org/10.1016/s1353-4858(04)00047-9|journal=Network Security|volume=2004|issue=3|pages=3|doi=10.1016/s1353-4858(04)00047-9|issn=1353-4858}}</ref><ref>{{Cite web|title=BioNTech moves to head of pack for COVID-19 vaccine with EU finance|url=https://www.eib.org/en/stories/eu-financing-for-covid-19-vaccine|access-date=3 February 2021|website=European Investment Bank|language=en}}</ref><ref name="PR June 11, 2020">{{cite web|language=en|author=<!--Not stated--> |title=Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing |url=https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1034 |publisher=[[European Commission]] |date=11 June 2020 |access-date=21 November 2020}}</ref>
Pada bulan Juni 2020, BioNTech mendapat €250 juta dari [[Temasek Holdings]] ([[Singapura]]) melalui pembelian saham dan obligasi konversi 4 tahun, serta dari investor lain melalui [[PMTHMETD]] [[obligasi konversi]] wajib.<ref>{{cite news|last=Burger|first=Ludwig|date=29 June 2020|title=Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech|work=[[Reuters]]|location=Frankfurt|url=https://www.reuters.com/article/us-biontech-placement/temasek-led-investor-group-in-250-million-vaccine-bet-on-germanys-biontech-idUSKBN2400PS|access-date=2 August 2020}}</ref>
Pada tanggal 15 September 2020, BioNTech mendapat hibah sebesar €375 juta dari Kementerian Pendidikan dan Riset Federal Jerman, untuk mempercepat pengembangan vaksin COVID-19.<ref>{{Cite web|last=SE|first=BioNTech|date=15 September 2020|title=BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162|url=http://www.globenewswire.com/news-release/2020/09/15/2093535/0/en/BioNTech-to-Receive-up-to-375M-in-Funding-from-German-Federal-Ministry-of-Education-and-Research-to-Support-COVID-19-Vaccine-Program-BNT162.html|access-date=3 February 2021|website=GlobeNewswire News Room}}</ref>
| |||